Related Experiment Videos
Infliximab in ulcerative colitis: is there a placebo (effect) in the house?
Gastroenterology
|June 14, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Impact of Upadacitinib on Cardiovascular Events and Lipid Values in Older Inflammatory Bowel Disease Patients With Baseline Cardiovascular Risk.
The American journal of gastroenterology·2026
Combining Guselkumab with Upadacitinib Is Safe and Effective in the Treatment of Medically Complex Inflammatory Bowel Disease.
Digestive diseases and sciences·2026
Colonic Tissue Expression of MAdCAM-1 Is Not Predictive of Vedolizumab Responsiveness in Inflammatory Bowel Disease.
Clinical and translational science·2025
A positive Clostridioides difficile test does not impact outcomes in hospitalized patients with acute severe ulcerative colitis.
Therapeutic advances in gastroenterology·2025
Safety and Efficacy of Upadacitinib in Patients with Inflammatory Bowel Disease After Liver Transplantation: A Case Series.
Digestive diseases and sciences·2025